newsfilter
← Latest News
GlobeNewswire·

PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development

Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC:PAOG) today republished its 2022 strategic update on the company's CBD pharmaceutical and nutraceutical development strategy. The update was originally released on Friday, January 2